Gene · 701
Papers3,969
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,969
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering tumor ecosystems at super resolution from spatial transcriptomics with TESLA. | Cell Syst | 2023 | 37164011 | PubTator, text mining | PubMed |
| Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. | Discov Oncol | 2023 | 37160815 | PubTator, text mining | PubMed |
| Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022. | Front Pharmacol | 2023 | 37153760 | PubTator, text mining | PubMed |
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
| Caspase cleaves Drosophila BubR1 to modulate spindle assembly checkpoint function and lifespan of the organism. | FEBS J | 2023 | 37151120 | PubTator, text mining | PubMed |
| Comparison of therapeutic effects of mesenchymal stem cells derived from superficial and deep subcutaneous adipose tissues. | Stem Cell Res Ther | 2023 | 37143086 | PubTator, text mining | PubMed |
| Author Correction: Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1. | Nat Aging | 2023 | 37130978 | PubTator, text mining | PubMed |
| β-Catenin-Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer. | Cancer Res | 2023 | 37129912 | PubTator, text mining | PubMed |
| The role of kinetochore dynein in checkpoint silencing is restricted to disassembly of the corona. | Mol Biol Cell | 2023 | 37126397 | PubTator, text mining | PubMed |
| SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123398 | PubTator, text mining | PubMed |
| Identification of key molecular players and associated pathways in cervical squamous cell carcinoma progression through network analysis. | Proteins | 2023 | 37119038 | PubTator, text mining | PubMed |
| Unique progerin C-terminal peptide ameliorates Hutchinson-Gilford progeria syndrome phenotype by rescuing BUBR1. | Nat Aging | 2023 | 37118121 | PubTator, text mining | PubMed |
| TEAD Inhibitors Sensitize KRASG12C Inhibitors via Dual Cell Cycle Arrest in KRASG12C-Mutant NSCLC. | Pharmaceuticals (Basel) | 2023 | 37111311 | PubTator, text mining | PubMed |
| Aurora B Inhibitors as Cancer Therapeutics. | Molecules | 2023 | 37110619 | PubTator, text mining | PubMed |
| Deciphering the Prognostic and Therapeutic Significance of Cell Cycle Regulator CENPF: A Potential Biomarker of Prognosis and Immune Microenvironment for Patients with Liposarcoma. | Int J Mol Sci | 2023 | 37108172 | PubTator, text mining | PubMed |
| Chromosomal instability and its effect on cell lines. | Cancer Rep (Hoboken) | 2023 | 37095005 | PubTator, text mining | PubMed |
| The establishment of mitotic errors-driven senescence depends on autophagy. | Redox Biol | 2023 | 37094517 | PubTator, text mining | PubMed |
| Gene dysregulation in acute HIV-1 infection - early transcriptomic analysis reveals the crucial biological functions affected. | Front Cell Infect Microbiol | 2023 | 37077524 | PubTator, text mining | PubMed |
| BUB-1 and CENP-C recruit PLK-1 to control chromosome alignment and segregation during meiosis I in C. elegans oocytes. | Elife | 2023 | 37067150 | PubTator, text mining | PubMed |
| Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. | Cell Death Discov | 2023 | 37059713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/701/papers?page=21